Showing results (51-60 of 75) with videos related to
Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|March 20, 2025
Immune checkpoint inhibitor therapy for aggressive pituitary neuroendocrine tumorsAndrew L Lin, Vasilisa Rudneva, Adam Newton, et al.Brain Pathology (Zurich, Switzerland)|October 10, 2017
Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysisAndrey Korshunov, Lukas Chavez, Tanvi Sharma, et al.Neuro-Oncology Practice|May 11, 2026
Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairmentNeil Sielski, Anne S Reiner, William E Rosa, et al.Nature Communications|December 13, 2017
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancerBarbara Oldrini, Wan-Ying Hsieh, Hediye Erdjument-Bromage, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2016
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal FluidElena I Pentsova, Ronak H Shah, Jiabin Tang, et al.JCO Precision Oncology|February 25, 2026
Noninvasive Identification of Isocitrate Dehydrogenase 1/2 Mutation in Brainstem GliomasMarina Kushnirsky, Andrew L Lin, Tejus Bale, et al.Acta Neuropathologica|April 22, 2010
Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettesAndrey Korshunov, Marc Remke, Marco Gessi, et al.Acta Neuropathologica|November 20, 2012
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)Andrey Korshunov, Marina Ryzhova, David T W Jones, et al.Neuro-Oncology|May 30, 2019
Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumorsHui Chen, Cheddhi Thomas, Felipe Andres Munoz, et al.Neuro-Oncology|November 5, 2025
Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS LymphomaAntonio Omuro, Lisa M DeAngelis, Mei-Yin C Polley, et al.Pageof 8